Hospira Inc. recalls Labetalol Hydrochloride Injection, USP, 100 mg/20 mL (5 mg/mL), 20 mL Multidose Vial, packaged 50/20 mL glass vials/cart
Recalled July 16, 2014 · FDA recall D-1424-2014 · Hospira
Hazard
Presence of Particulate Matter; metal embedded in the glass vial and visible particles floating in the solution · FDA Class II
Units
45,448 vials
Sold at
Nationwide
Description
Presence of Particulate Matter; metal embedded in the glass vial and visible particles floating in the solution
Product
Labetalol Hydrochloride Injection, USP, 100 mg/20 mL (5 mg/mL), 20 mL Multidose Vial, packaged 50/20 mL glass vials/carton, Hospira, Inc., Lake Forest, IL 60045 --- NDC 0409-2267-20
Manufacturer(s)
Hospira Inc.
Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →